Author

Concetta Martines

Observed names: C. Martines, Martines Concetta

Observed institution: Ospedale Garibaldi

OpenAlex ID: A5069349157

Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma

2015 · S. Cereda, M. Milella, et al. · Cancer Chemotherapy and Pharmacology · 15

Bevacizumab Plus Chemotherapy Cost Effectiveness

2015 · Roberto Bordonaro, Stefano Cordio, et al. · Journal of Clinical Oncology · 4

Efficacy of mitomycin C plus a fluoropyrimidine in pretreated patients with metastatic colorectal cancer eligible to regorafenib: Results of a retrospective study.

2015 · Federica Martorana, Stefano Sergio Cordio, et al. · Journal of Clinical Oncology · 2

Efficacy of A Fluoropyrimidine plus Mitomycin C in Pretreated Patients with Metastatic Colorectal Cancer Eligible for Regorafenib: A Retrospective Study

2017 · Federica Martorana, Paolo Vigneri, et al. · AIMS Medical Science · 1

Pertuzumab, Trastuzumab, Docetaxel: a single istitution clinical exeperience for Her2 positive metastatic breast cancer (mBC)

2016 · C. Martines, G. Lavenia, et al. · Annals of Oncology · 1

Inibizione sequenziale dell’angiogenesi nel carcinoma del colon-retto metastatico: attività ed efficacia di aflibercept in un caso clinico

2015 · Concetta Martines, Stefano Cordio, et al. · Recenti Progressi in Medicina · 1

Translational Challenges from the 2014 Gastrointestinal Cancers Symposium: Toward a True Tailored Therapy Through Effective Research

2014 · Giuseppe Aprile, Francesco Giuliani, et al. · Future Oncology · 1

Examining perceptions of financial toxicity among cancer patients: The Financial Toxicity 16 Questionnaire.

2020 · Roberto Bordonaro, Fabrizio Castagna, et al. · Journal of Clinical Oncology

レゴラフェニブに適格な転移性結腸直腸癌の前処理患者におけるフルオロピリミジン+マイトマイシンcの有効性:後ろ向き研究【jst・京大機械翻訳】

2017 · Martorana Federica, Vigneri Paolo, et al.

Screening of Psychological Distress in cancer patients at Oncological Reception Centre. Preliminary results

2016 · L. Carapezza, S. Cordio, et al. · Annals of Oncology

Concomitantly epirubicin and trastuzumab (the Buzdar Regimen) as neo-adjuvant chemotherapy in HER2-overexpressed early breast cancer: a real-life, retrospective, mono-institutional experience

2016 · G. Lavenia, C. Martines, et al. · Annals of Oncology

A data collection representative of an outcome analysis in advanced Non Small Cell Lung Cancer (NSCLC) expressing EGFR mutations after failure of first line therapy with Tyrosine Kinase Inhibitors (TKIs) with careful on post progression survival

2016 · C. Sergi, O. Commendatore, et al. · Annals of Oncology

The clinical governance model (UFA-ONCO-EMA model) for anticancer drugs delivering of the ARNAS Garibaldi: third year experience

2015 · G.E. Fassari, R. Bordonaro, et al. · Annals of Oncology

Efficacy of Mitomycin C plus a Fluoropyrimidine in pre-treated patients with metastatic colo-rectal cancer eligible to Regorafenib. Results of a retrospective study

2015 · C. Martines, S. Cordio, et al. · Annals of Oncology

Second- and Third-Line Chemotherapy in Advanced Gastric Cancer: a Real-Life Clinical Picture

2014 · M. Uccello, S. Cordio, et al. · Annals of Oncology

Safety and Efficacy of Preoperative Chemoradiotherapy (Crt) in Locally Advanced Rectal Cancers (Larc): a Retrospective Italian Survey of 389 Elderly Patients

2014 · C. Martines, S. Cordio, et al. · Annals of Oncology

Works count: 16

Citation count: 25

H-index: 2

I10-index: 1